Aldeyra Therapeutics, Inc.
Recent Filings
All 621 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 4 | 4 | Mar 20, 2026 |
| 4 | 4 | Mar 19, 2026 |
| 8-K | 8-K | Mar 17, 2026 |
| S-8 | S-8 | Feb 27, 2026 |
| 10-K | 10-K | Feb 27, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| 8-K | 8-K | Dec 31, 2025 |
| 8-K | 8-K | Dec 16, 2025 |
| SCHEDULE 13G/A | — | Nov 14, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Alfieri Michael | Principal Financial Officer | Purchase | 2,500 @ $5.30 | 2,500 | Aug 13, 2025 |
| Machatha Stephen | Chief Development Officer | Sale | 22,073 @ $5.15 | 221,799 | Aug 11, 2025 |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | — | Sale | 3,400,000 @ $1.42 | 5,875,851 | Apr 3, 2025 |
| Machatha Stephen | Chief Development Officer | Sale | 16,041 @ $4.74 | 236,771 | Aug 12, 2024 |
| Greenberg Bruce | See Remarks | Sale | 10,834 @ $4.74 | 126,382 | Aug 12, 2024 |
| EDELMAN JOSEPH | — | Purchase | 37,712 @ $4.74 | 9,275,851 | Apr 4, 2024 |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | — | Purchase | 186,051 @ $3.44 | 8,788,011 | Apr 3, 2024 |
| Machatha Stephen | Chief Development Officer | Sale | 18,231 @ $3.41 | 255,032 | Mar 12, 2024 |
| Machatha Stephen | Chief Development Officer | Sale | 11,537 @ $3.16 | 252,812 | Mar 12, 2024 |
| Greenberg Bruce | See Remarks | Sale | 13,201 @ $3.41 | 120,699 | Mar 11, 2024 |